Cover Image
市場調查報告書

高度惡性非何杰金氏淋巴瘤:全球臨床實驗檢討

High Grade Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 298070
出版日期 內容資訊 英文 66 Pages
訂單完成後即時交付
價格
Back to Top
高度惡性非何杰金氏淋巴瘤:全球臨床實驗檢討 High Grade Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014
出版日期: 2014年03月19日 內容資訊: 英文 66 Pages
簡介

本報告提供高度惡性非何杰金氏淋巴瘤的治療藥相關臨床實驗調查分析,提供臨床實驗數及被實驗人數,Phase別及各方面狀況,有潛力的企業,正在開發的治療藥的資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家

G7各國的臨床實驗:腫瘤科臨床實驗中高度惡性非何杰金氏淋巴瘤的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:階段別

各方面的臨床實驗

Phase別臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與高度惡性非何杰金氏淋巴瘤治療藥臨床實驗的主要企業

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Incyte Corporation
    • Amgen Inc.
  • 主要大學·研究機關·醫院臨床實驗概要
    • Memorial Sloan Kettering Cancer Center
    • National Cancer Institute
    • The Children's Hospital at Westmead
    • Mater Medical Research Institute
    • Lymphoma Trials Office
    • Cancer Treatment Centers of America
    • Ottawa Regional Cancer Foundation
    • Case Comprehensive Cancer Center
    • Albert Einstein College of Medicine of Yeshiva University
    • Johann Wolfgang Goethe University Hospitals

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2037CTIDB

GlobalData's clinical trial report, "High Grade Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the High Grade Non-Hodgkin Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on High Grade Non-Hodgkin Lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating High Grade Non-Hodgkin Lymphoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • High Grade Non-Hodgkin Lymphoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of High Grade Non-Hodgkin Lymphoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of High Grade Non-Hodgkin Lymphoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Incyte Corporation
      • Clinical Trial Overview of Incyte Corporation
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • The Children's Hospital at Westmead
      • Clinical Trial Overview of The Children's Hospital at Westmead
      • Mater Medical Research Institute
      • Clinical Trial Overview of Mater Medical Research Institute
      • Lymphoma Trials Office
      • Clinical Trial Overview of Lymphoma Trials Office
      • Cancer Treatment Centers of America
      • Clinical Trial Overview of Cancer Treatment Centers of America
      • Ottawa Regional Cancer Foundation
      • Clinical Trial Overview of Ottawa Regional Cancer Foundation
      • Case Comprehensive Cancer Center
      • Clinical Trial Overview of Case Comprehensive Cancer Center
      • Albert Einstein College of Medicine of Yeshiva University
      • Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University
      • Johann Wolfgang Goethe University Hospitals
      • Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of High Grade Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Terminated Clinical Trials, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • High Grade Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Incyte Corporation, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital at Westmead, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mater Medical Research Institute, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Lymphoma Trials Office, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Treatment Centers of America, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Regional Cancer Foundation, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2014*

List of Figures

  • High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of High Grade Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • High Grade Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • High Grade Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • GlobalData Methodology
Back to Top